Results 101 to 110 of about 22,011 (155)

Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity. [PDF]

J Pharmacol Exp Ther
Schulte AJ, Lewellen M, Durose W, Nolan E, Taghizadeh L, Todhunter D, Bush C, Lang HP, Brown ME, DePauw TA, Makielski KM, Kim JH, Burt LE, Overn P, Forster CL, Seelig DM, O'Sullivan MG, Weigel BJ, Murugan P, Cutter GR, Lund TC, Vallera DA, Modiano JF.   +22 more
europepmc   +1 more source

A Contemporary Review of Plasminogen Activator Inhibitor Type 1: Structure, Function, Genetic Architecture, and Intracellular/Extracellular Roles. [PDF]

TH Open
Wortley J, Vu J, Soogoor N, Becerra M, Sathyamoorthy M.   +4 more
europepmc   +1 more source

Integrin α5β1 mediates the inhibitory effects of vasoinhibin on angiogenesis and vascular permeability. [PDF]

J Biol Chem
Zamora M, Clapp C, Martínez de la Escalera G, Robles JP.   +3 more
europepmc   +1 more source

Pathogenic and Regulatory Roles of Fibrinolytic Factors in Autoimmune Diseases. [PDF]

Curr Issues Mol Biol
Kanno Y.
europepmc   +1 more source

409. Inhibition of Urokinase Receptor (uPAR) Expression by RNA-Cleaving Catalytic DNA (DNAzyme) Containing Antisense uPAR [PDF]

Molecular Therapy, 2002
openaire   +1 more source

Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]

Arterioscler Thromb Vasc Biol
Hisada Y, Mackman N.
europepmc   +1 more source

Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]

Front Immunol
Napolitano F, Mormile I, Mignogna G, de Paulis A, Rossi FW, Montuori N.   +5 more
europepmc   +1 more source

Insights from the Evolution of Coagulation: A New Perspective on Anti-Inflammatory Strategies in the ICU-Focus on the Contact Activation System. [PDF]

Biomedicines
Wang R, Zhu F.
europepmc   +1 more source

The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma. [PDF]

J Biol Chem
Zampieri C, Kouhmareh K, Sartipdolagh P, Azmoon P, Klemke RL, Gonias SL.   +5 more
europepmc   +1 more source

Ly6/uPAR Protein from Asterias rubens Starfish Stimulates Migration and Invasion of Human Epithelial and Immune Cells. [PDF]

Mar Drugs
Lyukmanova EN, Gornostaeva TY, Shabelnikov SV, Shenkarev ZO, Kirpichnikov MP, Paramonov AS, Bychkov ML.   +6 more
europepmc   +1 more source